Y Zhang, H Ma - Journal of thoracic disease, 2023 - pubmed.ncbi.nlm.nih.gov
Background Non-small cell lung cancer (NSCLC) is the most common malignancy in lung cancer, with a low survival rate and unfavorable prognosis. Dysregulated long non-coding …
Background: Non-small cell lung cancer (NSCLC) is the most common malignancy in lung cancer, with a low survival rate and unfavorable prognosis. Dysregulated long non-coding …
Y Zhang, H Ma - Journal of Thoracic Disease, 2023 - europepmc.org
Background Non-small cell lung cancer (NSCLC) is the most common malignancy in lung cancer, with a low survival rate and unfavorable prognosis. Dysregulated long non-coding …
Y Zhang, H Ma - Journal of Thoracic Disease, 2023 - jtd.amegroups.org
Background: Non-small cell lung cancer (NSCLC) is the most common malignancy in lung cancer, with a low survival rate and unfavorable prognosis. Dysregulated long non-coding …
Background: Non-small cell lung cancer (NSCLC) is the most common malignancy in lung cancer, with a low survival rate and unfavorable prognosis. Dysregulated long non-coding …
Y Zhang, H Ma - Journal of Thoracic Disease, 2023 - jtd.amegroups.org
LncRNA HOXD-AS2 regulates miR-3681-5p/DCP1A axis to promote the progression of non-small cell lung cancer - Zhang - Journal of Thoracic Disease Have a website account?Log In orRegister …